RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
- Research and development, 2025
- $261M
- YoY, 2025
- −18.1%
- 5-year CAGR
- +21.2%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $261M | −18.1% |
| 2024 | $319M | −3.3% |
| 2023 | $330M | +34.0% |
| 2022 | $246M | +42.7% |
| 2021 | $173M | +72.9% |
| 2020 | $100M | +42.0% |
| 2019 | $70M | — |